Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.05.179
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2005
Authors
Publisher
American Society of Clinical Oncology (ASCO)